Inhibition of hepatic stellate cell activation following Yinchenhao decoction administration to dimethylnitrosamine‐treated rats
- 5 August 2008
- journal article
- Published by Wiley in Hepatology Research
- Vol. 38 (9) , 919-929
Abstract
Aim: In an effort to investigate the mechanism by which Yinchenhao decoction (YCHD) acts on liver injury, we investigated the potential antifibrogenic effects of YCHD in an experimental liver fibrosis rat model, with special focus on the mechanisms inhibiting the activation and promoting apoptosis of hepatic stellate cells (HSC).Methods: The rats were initially randomized into two groups: the control (n = 10) and dimethylnitrosamine‐treated (DMN; n = 30) groups. DMN (10 mg/kg body weight) was administered intraperitoneally to the DMN‐treated rats for three consecutive days each week. At the end of the second week, three rats from the control and six rats from the DMN‐treated groups were killed for the fibrosis development assessment. The remaining DMN rats were further randomized into two groups: the DMN–water group (n = 12) and the DMN–YCHD group (n = 12). Both groups continued to receive weekly DMN treatment for another 2 weeks in addition to daily administration of either water or YCHD, which were given intragastrically at a dose of 0.418 g/100 g body weight.Results: Hepatic hydroxyproline content decreased and had improved histopathology in the DMN–YCHD rats. Compared to the DMN group, α‐smooth muscle actin (SMA) and CD68 expression in the DMN–YCHD group was reduced significantly; however, α‐SMA‐positive HSC apoptosis was not observed by confocal microscopy; Fibrogenic proteins (tissue inhibitor matrix proteinases‐1 and 2 and matrix metalloproteinase [MMP]‐2/14) and cytokines (tumor necrosis factor‐α and transforming growth factor‐β1) were decreased; MMP‐9 was significantly upregulated.Conclusion: Yinchenhao administration attenuates liver fibrosis at least in part by inhibiting HSC activation directly, rather than promoting cell apoptosis of activated HSC, and the suppressive activation of Kupffer cells.Keywords
This publication has 44 references indexed in Scilit:
- The herbal medicine inchin-ko-to (TJ-135) induces apoptosis in cultured rat hepatic stellate cellsLife Sciences, 2006
- The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosisApoptosis, 2005
- Yin Zhi Huang and other plant-derived preparations: where herbal and molecular medicine meetJournal of Hepatology, 2004
- Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosisJournal of Hepatology, 2004
- Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in ratsJournal of Hepatology, 2004
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1Journal of Hepatology, 1999
- Delayed fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNFαHepatology, 1998
- Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinusoidal lipocytes)Journal of Hepatology, 1993
- Correlation between Ito cells and fibrogenesis in an experimental model of hepatic fibrosis. A sequential stereological studyLiver International, 1983